New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

These meds are sometimes prescribed off-label for people with overweight or obesity. Most of these diabetes drugs promote weight loss by suppressing appetite and making you feel fuller. You might have ...

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including ...

Roughly one out of every two people who start taking semaglutide (Wegovy; Novo Nordisk) to lose weight will stop taking the medication within a year, according to a large population-based study out of ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Half of patients on the weight loss drug semaglutide who do not have diabetes stop taking it within a year. This is the discovery of a population-wide study that looked into adults who started taking ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Some medications FDA-approved for type 2 diabetes can promote weight loss. Diabetes medications for weight loss include Ozmepic®, ...